Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

New England Journal of Medicine - Tập 363 Số 8 - Trang 711-723 - 2010
F. Stephen Hodi1, Steven O’Day2, David F. McDermott3, Robert Weber4, Jeffrey A. Sosman5, John B.A.G. Haanen6, René González7, Caroline Robert8, Dirk Schadendorf9, Jessica C. Hassel10, Wallace Akerley11, Alfons J.M. van den Eertwegh12, Jose Lutzky13, Paul Lorigan14, Julia Vaübel9, Gerald P. Linette15, David Hogg16, Christian H. Ottensmeier17, Célèste Lebbé18, Christian Peschel19, Ian Quirt16, Joseph I. Clark20, Jedd D. Wolchok21, Jeffrey S. Weber22, Jing Tian23, M. J. Yellin23, G. Nichol23, Axel Hoos24, Walter J. Urba25
1Dana-Farber Cancer Institute, Boston, MA 02115, USA. [email protected]
2Angeles Clinic and Research Institute
3Beth Israel Deaconess Medical Center
4St. Mary's Medical Center
5Vanderbilt University Medical Center, Nashville
6Netherlands Cancer Institute
7University of Colorado, Cancer Center, Aurora
8Institut Gustave Roussy
9University Hospital Essen, Essen
10German Cancer Research Center, University of Mannheim, Mannheim
11Huntsman Cancer Institute, Salt Lake City
12VU university medical center;
13Mount Sinai Comprehensive Cancer Center, Miami
14Christie Hospital NHS Trust, Manchester
15Washington University, ST. Louis
16Princess Margaret Hospital, Toronto
17Southampton University Hospitals, Southampton
18Saint Louis Hospital, Paris
19Technical University Munich, Munich
20Loyola University Medical Center, Maywood, IL
21Memorial-Sloan Kettering Cancer Center
22H. Lee Moffitt Cancer Center, Tampa, FL
23Medarex Inc.
24Bristol-Myers Squibb, Wallingford, CT
25Earle A. Chiles Research Institute, Portland, OR

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1038/nature05661

10.1111/j.1365-2133.2004.05708.x

10.1056/NEJMra041245

10.1586/era.09.25

10.1016/j.ejca.2004.04.030

10.1016/j.ctrv.2007.04.003

10.2146/ajhp080460

10.1038/nrc2051

10.1002/cncr.23086

10.1200/JCO.2008.17.8954

Robert C, 2009, Oncologist, 14, 848, 10.1634/theoncologist.2009-0028

10.1007/s00262-008-0653-8

10.1158/1078-0432.CCR-09-1024

10.1016/S1470-2045(09)70334-1

10.1245/ASO.2005.03.536

10.1097/CMR.0b013e328333bbc8

10.1200/JCO.2005.06.205

10.1158/1078-0432.CCR-07-0187

10.1038/nm1100

Schwartzentruber DJ, 2009, J Clin Oncol, 27, 463s, 10.1200/jco.2009.27.18_suppl.cra9011

10.1097/00000421-198212000-00014

10.1093/jnci/91.6.523

10.1200/JCO.2007.12.7837

10.1080/07357900802027073

10.1158/1078-0432.CCR-05-1544

Morton DL, 2007, J Clin Oncol, 25, 474s, 10.1016/j.clon.2013.04.009

Eggermont AM, 2008, J Clin Oncol, 26, 484s, 10.1200/jco.2008.26.15_suppl.9004

10.1200/JCO.2007.11.9941

10.1200/JCO.2002.08.072

10.1158/1078-0432.CCR-09-1624

Eisen T, 2010, Cancer, 116, 146, 10.1002/cncr.24686

10.1200/JCO.2007.15.7636

10.1634/theoncologist.12-7-864

Lin R, 2008, J Clin Oncol, 26, 497s

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 363 Số 8

711-723

Thông tin tác giả